3/25/2024
Aachen, Germany, 25 March 2024 – Grünenthal, the leading pharmaceutical company in pain research and management, released its 2023 full-year results, announcing a double-digit revenue growth.
A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.
Florian Dieckmann
Head Global Corporate Affairs & Communication
Grünenthal GmbH
52099 Aachen
Phone +49 241 569 2555
Fabia Kehren
Head of External Communication and Editorial Management
Grünenthal GmbH
52099 Aachen
Phone +49 241 569-3269
E-Mail Fabia.Kehren@grunenthal.com